{"transactions":[{"id":1211734,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":82113,"kind":"person","name":"Wargacki Stephen","position":1,"cik":"0001960165","reported_name":"Wargacki Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2025-03-11T21:49:10.000Z","date":"2025-03-07","kind":"grant","planned":false,"acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment."}],"balance_after":65000,"derivative":{"exercise_price":2.65,"expiration_date":"2035-03-07","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001214659-25-004228","document":"marketforms-68577.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465925004228/marketforms-68577.xml","form_type":"4"}},{"id":1211733,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":82113,"kind":"person","name":"Wargacki Stephen","position":1,"cik":"0001960165","reported_name":"Wargacki Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2025-03-11T21:49:10.000Z","date":"2025-03-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":4572,"price":2.54,"value":11612.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units (\"RSUs\") previously granted to the Reporting Person."}],"balance_after":343552,"source":{"system":"sec-edgar","filing":"0001214659-25-004228","document":"marketforms-68577.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465925004228/marketforms-68577.xml","form_type":"4"}},{"id":1211732,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":82113,"kind":"person","name":"Wargacki Stephen","position":1,"cik":"0001960165","reported_name":"Wargacki Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2025-03-11T21:49:10.000Z","date":"2025-03-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":15431,"price":2.65,"value":40892.15,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units (\"RSUs\") previously granted to the Reporting Person."}],"balance_after":348124,"source":{"system":"sec-edgar","filing":"0001214659-25-004228","document":"marketforms-68577.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465925004228/marketforms-68577.xml","form_type":"4"}},{"id":1211731,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":82113,"kind":"person","name":"Wargacki Stephen","position":1,"cik":"0001960165","reported_name":"Wargacki Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2025-03-11T21:49:10.000Z","date":"2025-03-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":12859,"price":2.65,"value":34076.35,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units (\"RSUs\") previously granted to the Reporting Person."}],"balance_after":363555,"source":{"system":"sec-edgar","filing":"0001214659-25-004228","document":"marketforms-68577.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465925004228/marketforms-68577.xml","form_type":"4"}},{"id":1211730,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":82113,"kind":"person","name":"Wargacki Stephen","position":1,"cik":"0001960165","reported_name":"Wargacki Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2025-03-11T21:49:10.000Z","date":"2025-03-07","kind":"grant","planned":false,"acquired":true,"shares":115000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment."}],"balance_after":376414,"source":{"system":"sec-edgar","filing":"0001214659-25-004228","document":"marketforms-68577.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465925004228/marketforms-68577.xml","form_type":"4"}},{"id":1393826,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":82113,"kind":"person","name":"Wargacki Stephen","position":1,"cik":"0001960165","reported_name":"Wargacki Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2024-10-02T18:15:47.000Z","date":"2024-03-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":19505,"price":4.88,"value":95184.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units (\"RSUs\") previously granted to the Reporting Person. This amended Form 4 is being filed to revise the number of shares withheld by the issuer to satisfy tax withholding obligations originally reported on form 4 filed on March 12, 2024 ."}],"balance_after":261414,"source":{"system":"sec-edgar","filing":"0001214659-24-017010","document":"marketforms-67100.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465924017010/marketforms-67100.xml","form_type":"4/A","original_submission_date":"2024-03-12"}},{"id":1518827,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":82113,"kind":"person","name":"Wargacki Stephen","position":1,"cik":"0001960165","reported_name":"Wargacki Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2024-05-13T17:40:32.000Z","date":"2024-05-10","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment."}],"balance_after":267963,"source":{"system":"sec-edgar","filing":"0001214659-24-008874","document":"marketforms-65653.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465924008874/marketforms-65653.xml","form_type":"4"}},{"id":1580507,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":82113,"kind":"person","name":"Wargacki Stephen","position":1,"cik":"0001960165","reported_name":"Wargacki Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Research & Development"}}],"security":"Common Stock","published_at":"2024-03-12T17:46:17.000Z","date":"2024-03-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":1687,"price":4.88,"value":8232.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units (\"RSUs\") previously granted to the Reporting Person."}],"balance_after":257963,"source":{"system":"sec-edgar","filing":"0001214659-24-004391","document":"marketforms-65149.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465924004391/marketforms-65149.xml","form_type":"4"}},{"id":1580506,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":82113,"kind":"person","name":"Wargacki Stephen","position":1,"cik":"0001960165","reported_name":"Wargacki Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Research & Development"}}],"security":"Common Stock","published_at":"2024-03-12T17:46:17.000Z","date":"2024-03-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":11269,"price":4.88,"value":54992.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units (\"RSUs\") previously granted to the Reporting Person."}],"balance_after":259650,"source":{"system":"sec-edgar","filing":"0001214659-24-004391","document":"marketforms-65149.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465924004391/marketforms-65149.xml","form_type":"4"}},{"id":1583723,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":82113,"kind":"person","name":"Wargacki Stephen","position":1,"cik":"0001960165","reported_name":"Wargacki Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Research & Development"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2024-03-11T14:34:53.000Z","date":"2024-03-07","kind":"grant","planned":false,"acquired":true,"shares":56250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment."}],"balance_after":56250,"derivative":{"exercise_price":5.68,"expiration_date":"2034-03-07","underlying":"Common Stock","underlying_shares":56250},"source":{"system":"sec-edgar","filing":"0001214659-24-004302","document":"marketforms-64695.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465924004302/marketforms-64695.xml","form_type":"4"}},{"id":1583722,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":82113,"kind":"person","name":"Wargacki Stephen","position":1,"cik":"0001960165","reported_name":"Wargacki Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Research & Development"}}],"security":"Common Stock","published_at":"2024-03-11T14:34:53.000Z","date":"2024-03-07","kind":"grant","planned":false,"acquired":true,"shares":112500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment."}],"balance_after":270919,"source":{"system":"sec-edgar","filing":"0001214659-24-004302","document":"marketforms-64695.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465924004302/marketforms-64695.xml","form_type":"4"}},{"id":1583721,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":82113,"kind":"person","name":"Wargacki Stephen","position":1,"cik":"0001960165","reported_name":"Wargacki Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Research & Development"}}],"security":"Common Stock","published_at":"2024-03-11T14:34:53.000Z","date":"2023-03-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":1981,"price":0.7937,"value":1572.3197,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units (\"RSUs\") previously granted to the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The original Form 3, filed on 1/1/23, is being amended by this Form 4 amendment solely to correct an administrative error, which misreported the inclusion of shares vested that occurred on 3/10/22 as a total of 4,663 shares vested and owned when in fact 3,107 shares of the Issuer's common stock were owned, net of taxes withheld. As a result of this administrative error, the number of shares beneficially owned by the reporting person following the corrected transaction reflects a reduction in the number of shares reported as beneficially owned by the reporting person by 1,556 shares reflecting share withheld for the payment of taxes."}],"balance_after":158419,"source":{"system":"sec-edgar","filing":"0001214659-24-004302","document":"marketforms-64695.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465924004302/marketforms-64695.xml","form_type":"4"}},{"id":1811758,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":82113,"kind":"person","name":"Wargacki Stephen","position":1,"cik":"0001960165","reported_name":"Wargacki Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Research & Development"}}],"security":"Performance Stock Units","published_at":"2023-08-09T20:30:29.000Z","date":"2023-08-09","kind":"grant","planned":false,"acquired":true,"shares":67500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each performance-based stock unit (\"PSU\") represents a contingent right to receive one share of the Company's Common Stock. The PSUs have a Performance Period beginning on the Grant Date and ending on May 5, 2026 and, to the extent earned, will vest 100% on that date, subject to the grantee's continued employment or other service with the Company from the Grant Date through the last day of the Performance Period. The number of shares of Common Stock that will be earned at the end of the Performance Period is subject to increase or decrease from 50% to up to 150%, based on the achievement of pre-established Performance Price metrics. The Performance Price for these PSUs is defined as the 30-day average of the closing price of the Company shares as reported on the Nasdaq Stock Market immediately prior to and including the last calendar day of the Performance Period."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each performance-based stock unit (\"PSU\") represents a contingent right to receive one share of the Company's Common Stock. The PSUs have a Performance Period beginning on the Grant Date and ending on May 5, 2026 and, to the extent earned, will vest 100% on that date, subject to the grantee's continued employment or other service with the Company from the Grant Date through the last day of the Performance Period. The number of shares of Common Stock that will be earned at the end of the Performance Period is subject to increase or decrease from 50% to up to 150%, based on the achievement of pre-established Performance Price metrics. The Performance Price for these PSUs is defined as the 30-day average of the closing price of the Company shares as reported on the Nasdaq Stock Market immediately prior to and including the last calendar day of the Performance Period."}],"balance_after":67500,"derivative":{"expiration_date":"2026-05-05","underlying":"Common Stock","underlying_shares":67500},"source":{"system":"sec-edgar","filing":"0001214659-23-010924","document":"marketforms-61880.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465923010924/marketforms-61880.xml","form_type":"4"}},{"id":1902275,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":82113,"kind":"person","name":"Wargacki Stephen","position":1,"cik":"0001960165","reported_name":"Wargacki Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Research & Development"}}],"security":"Performance Stock Units","published_at":"2023-05-05T20:00:49.000Z","date":"2023-05-05","kind":"grant","planned":false,"acquired":true,"shares":67500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Performance Stock Unit (\"PSU\") represents a contingent right to receive one share of Aquestive (\"Company\") common stock. The PSUs have a three-year Performance Period, and, to the extent earned, will vest 100% on the third anniversary of the grant date, subject to the grantee's continued employment or other service with the Company or any Subsidiary from the Grant Date through the last day of the Performance Period. The number of shares of Common Stock that will be earned at the end of the three-year Performance Period is subject to increase or decrease based on the results of the Performance Price. The Performance Price for these PSUs is defined as the 30-day average of the closing price of the Company shares as reported on the Nasdaq Stock Market immediately prior to and including the last calendar day of the Performance Period."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Performance Stock Unit (\"PSU\") represents a contingent right to receive one share of Aquestive (\"Company\") common stock. The PSUs have a three-year Performance Period, and, to the extent earned, will vest 100% on the third anniversary of the grant date, subject to the grantee's continued employment or other service with the Company or any Subsidiary from the Grant Date through the last day of the Performance Period. The number of shares of Common Stock that will be earned at the end of the three-year Performance Period is subject to increase or decrease based on the results of the Performance Price. The Performance Price for these PSUs is defined as the 30-day average of the closing price of the Company shares as reported on the Nasdaq Stock Market immediately prior to and including the last calendar day of the Performance Period."}],"balance_after":67500,"derivative":{"expiration_date":"2026-05-05","underlying":"Common Stock","underlying_shares":67500},"source":{"system":"sec-edgar","filing":"0001214659-23-006560","document":"marketforms-61242.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465923006560/marketforms-61242.xml","form_type":"4"}},{"id":1960664,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":82113,"kind":"person","name":"Wargacki Stephen","position":1,"cik":"0001960165","reported_name":"Wargacki Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Research & Development"}}],"security":"Common Stock","published_at":"2023-03-09T20:06:20.000Z","date":"2023-03-09","kind":"grant","acquired":true,"shares":135000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment."}],"balance_after":161956,"source":{"system":"sec-edgar","filing":"0001214659-23-003689","document":"marketforms-59532.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1398733/000121465923003689/marketforms-59532.xml","form_type":"4"}}]}